ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Kite Pharma, Inc.

Kite Pharma, Inc. (KITE)

179.79
0.00
(0.00%)
Cerrado 04 Enero 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
179.79
Postura de Compra
107.00
Postura de Venta
179.99
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
179.79
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KITE Últimas noticias

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a wholly-owned subsidiary of Gilead (“Purchaser”...

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of the tender offer by its wholly-owned subsidiary, Dodgers Merger Sub, Inc. (“Purchaser”), for all of the...

Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period

Gilead Sciences, Inc. (Nasdaq: GILD) and Kite Pharma, Inc. (Nasdaq: KITE) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE PR Newswire NEW YORK, Aug. 31, 2017 NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan...

Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc.

Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc. PR Newswire NEW YORK, Aug. 29, 2017 NEW YORK, Aug. 29, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kite Pharma, Inc.

Rowley Law PLLC is investigating potential claims against Kite Pharma, Inc. (NASDAQ: KITE) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of...

Gilead Sciences to Acquire Kite Pharma for $11.9 Billion

-- Immediately Positions Gilead as a Leader in Cell Therapy -- -- Kite’s Lead CAR T Therapy Candidate, Axicabtagene Ciloleucel, Under Priority Review in the U.S. and Expedited Review in...

Kite Highlights Publication from the National Cancer Institute Demonstrating Responses in Patients with Metastatic Solid Tumo...

Study Demonstrates the Potential of TCR Engineered T-Cell Therapy to Induce Remissions in Solid Tumors KITE-718, Utilizing Same TCR Construct and Next-Generation T-Cell Manufacturing...

Kite Reports Second Quarter 2017 Financial Results

Filed Industry’s First CAR-T Marketing Authorization Application in Europe for Axicabtagene Ciloleucel for Potential EU Approval and Launch in 2018 Submitted Investigational New Drug...

Kite Submits Investigational New Drug (IND) Application for KITE-585, Anti-BCMA CAR-T Therapy Candidate for Multiple Myeloma

Internally Generated Cell Therapy Candidate Engineered with Fully Human Anti-BCMA Construct Next-Generation Manufacturing Process Designed for Enhanced Product Potency and Activity...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

KITE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de KITE PHARMA, INC.?
El precio actual de las acciones de KITE PHARMA, INC. es US$ 179.79
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de KITE PHARMA, INC.?
KITE PHARMA, INC. ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
US$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M
glenn1919 glenn1919 1 minuto hace
vvpr............................https://stockcharts.com/h-sc/ui?s=Vvpr&p=W&b=5&g=0&id=p86431144783
VVPR
Chartmaster Chartmaster 2 minutos hace
Yeah sure, and don't forget to read the prospectus right? LMAO!!!😃
RDAR
glenn1919 glenn1919 2 minutos hace
rzlv.............................https://stockcharts.com/h-sc/ui?s=rzlv&p=W&b=5&g=0&id=p86431144783
RZLV
Dynk Dynk 3 minutos hace
Have stepped away from most of this for the holidays and hunkered down in small remote area with limited...very limited interwebs, lol. Cant get onto OTC to see if the 1.7 bill shares have been removed yet, or will that be effective when achieve compliance under telavantis? Cheers everyone, here's
NBRI
Tray88 Tray88 3 minutos hace
Me too
FNMA
Tiger Money Tiger Money 3 minutos hace
Well written 
RDGL
81vette 81vette 4 minutos hace
BNRG,zero borrow/155% fee
BNRG
glenn1919 glenn1919 4 minutos hace
vrpx......https://stockcharts.com/h-sc/ui?s=Vrpx&p=W&b=5&g=0&id=p86431144783
VRPX
Tray88 Tray88 4 minutos hace
Me too
FNMA
Trendchanger1 Trendchanger1 5 minutos hace
Do you know Actipatch is consider under no pain act?
BIEL
govprs govprs 5 minutos hace
Yep.  I never doubted this but like many frustrated by lack of communication.  The Q3 report is why I added share from late November thru end of December.  Things are looking up but I emphasize for clarity we are still in early stages of a turnaround.  To make money here will require patience.  I'm
GDVM
tedpeele tedpeele 6 minutos hace
A pump campaign is in force. Have you not noticed?

That’s why they so heavily teamed up against me yesterday. They don’t want my message to get through and mess up their campaign.

A group is pumping this going into the January 9 conference call.

I think
LWLG
glenn1919 glenn1919 6 minutos hace
acon......om.....https://stockcharts.com/h-sc/ui?s=acon&p=W&yr=1&mn=3&dy=0&id=p96837884856
jimr1717 jimr1717 6 minutos hace
For sure.
Magnum7419 Magnum7419 7 minutos hace
TY for that info i will contact the SEC asap

k
Market manipulation comes in many shapes and forms, and it’s always prohibited. When a financial professional engages in an activity that artificially influences the price of a security, they manipulate the market. We’ll cover the
AHRO
baltimorebullet baltimorebullet 7 minutos hace
I've been hoping for that for years.
AVXL
sumbuysumsell sumbuysumsell 7 minutos hace
It says running Version 4 here. Further response below. I'll take this no further, time to get outside with plans to get to a lake and more today.
Q- Do other versions of ChatGPT accept PDF file input?
A- As of now, no version of ChatGPT, including GPT-3 and GPT-4, has the ability to
AVXL
Tiger Money Tiger Money 7 minutos hace
Gives me a chance to still load at these cheap prices!
MNMD
glenn1919 glenn1919 7 minutos hace
acon................https://stockcharts.com/h-sc/ui?s=acon&p=W&b=5&g=0&id=p86431144783
ACON
blackhawks blackhawks 7 minutos hace
We need more bible thumping from sanctimonious MAGAts

https://i.imgur.com/7HuARdH.jpeg
BullNBear52 BullNBear52 8 minutos hace
I'm sure Musk is worried about BYD entering the US market.
BYD
blackhawks blackhawks 8 minutos hace
We need more bible thumping from sanctimonious MAGAts

https://i.imgur.com/7HuARdH.jpeg
bri123 bri123 8 minutos hace
Lets hope it happens. A lot of 2s to get through.
ONCI

Su Consulta Reciente

Delayed Upgrade Clock